beta-lactams has been researched along with Atypical Mycobacterial Infection, Disseminated in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Composto, K; Kreiswirth, BN; Kurepina, N; Nuermberger, EL; Rifat, D | 1 |
| Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
| Chiarelli, LR; Degiacomi, G; Gutierrez, DL; Pasca, MR; Recchia, D; Stamilla, A; Stelitano, G | 1 |
| Daher, W; Johansen, MD; Kozikowski, AP; Kremer, L; Onajole, OK; Ordway, D; Raynaud, C; Roquet-Banères, F; Stec, J | 1 |
| Fisher, S; Galanis, C; Gupta, C; Kaushik, A; Lamichhane, G; Parrish, N; Story-Roller, E | 1 |
| Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
| Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM | 1 |
| Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T | 1 |
| Katoh, N; Morihara, K; Morihara, T; Takenaka, H | 1 |
| Amitani, R; Kimoto, T; Suzuki, K; Tanaka, E; Tsuyuguchi, K | 1 |
| Kobayashi, C; Sakai, T; Shinohara, M | 1 |
1 review(s) available for beta-lactams and Atypical Mycobacterial Infection, Disseminated
10 other study(ies) available for beta-lactams and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on β-Lactam Susceptibility.
Topics: Anti-Bacterial Agents; beta-Lactams; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Peptidoglycan | 2022 |
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Colony Count, Microbial; Drug Synergism; Humans; Imipenem; Indoles; Macrophages; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2020 |
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2016 |
Cutaneous Mycobacterium chelonae infection successfully treated with faropenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Infectious; Treatment Outcome | 2011 |
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection.
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Humans; Lactams; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous | 2002 |
Mycobacterium peregrinum infection in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; Humans; Imipenem; Lactams; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; RNA, Viral | 2005 |